Faculty profile

Dominik Mertz

ResearcherInfectious DiseasesMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Dominik Mertz

Researcher

Infectious Diseases

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
No publications since 2019.
Principal investigator on 3 research grants (3 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

124

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Bacteremia Randomized Controlled Trial Platform Trial Bloodstream Infection Endocarditis Enterococcus Antithrombotic Therapy Staphylococcus Aureus

Latest papers

Trends in health care–associated infections in acute care hospitals in Canada: an analysis of repeated point-prevalence surveys
CANADIAN MEDICAL ASSOCIATION JOURNAL · 2019
The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009–2015)
CANADIAN MEDICAL ASSOCIATION JOURNAL · 2018

All 2 publications

Latest funding

Treatment of Enterococcal Bacteremia Platform (TENT)
CIHR · 2026 · Principal investigator
$1,946,926
An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform
CIHR · 2024 · Co-investigator
$1,683,000
Clopidogrel vs. Aspirin in S. aureus Bacteremia (Clopido-SNAP)
CIHR · 2024 · Principal investigator
$539,325

All 9 grants and awards

Treatment of Enterococcal Bacteremia Platform (TENT)

Principal investigatorCIHR2026Project Grant

Principal investigators: Lee, Todd C; Briggs, Simon; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Golchi, Shirin; Goodman, Anna L; Hasse, Barbara; Kuehl, Richard; Martin, Yonas; McDonald, Emily G; Mertz, Dominik; Paul, Mical; Sligl, Wendy I; Somayaji, Ranjani; Speich, Benjamin; Tong, Steven; Walls, Genevieve

Keywords: Bacteremia; Bloodstream Infection; Endocarditis; Enterococcus; Platform Trial; Randomized Controlled Trial

$1,946,926

An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform

Co-investigatorCIHR2024Project Grant

Principal investigators: Lee, Todd C; Benedetti, Andrea; Bhagani, Sanjay; Boyles, Tom; Butler-Laporte, Guillaume; Cheng, Matthew P; McDonald, Emily G; McGuinty, Michaeline; Nakashima, Kei; Schwartz, Ilan S; Slavin, Monica; So, Miranda; Tan, Darrell H; Yong, Michelle

Keywords: Immunomodulation; Platform Trial; Pneumocystis; Pneumonia; Randomized Controlled Trial; Secondary Prophylaxis; Treatment

$1,683,000

Clopidogrel vs. Aspirin in S. aureus Bacteremia (Clopido-SNAP)

Principal investigatorCIHR2024Project Grant

Principal investigators: Lee, Todd C; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Lawler, Patrick R; McDonald, Emily G; Mertz, Dominik; Paul, Mical; Siegal, Deborah M; Tong, Steven; Walls, Genevieve

Keywords: Antithrombotic Therapy; Bacteremia; Randomized Controlled Trial; Staphylococcus Aureus

$539,325

Dabigatran for the adjunctive treatment of Staphylococcus aureus bacteremia: the DABI-SNAP nested randomized controlled trial

Principal investigatorCIHR2024Project Grant

Principal investigators: McDonald, Emily G; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Lawandi, Alexander; Lawler, Patrick R; Lee, Todd C; Mertz, Dominik; Paul, Mical; Siegal, Deborah M; Tong, Steven; Walls, Genevieve

Keywords: Adjunctive Therapies; Anticoagulants; Comparative Effectiveness Trial; Desirability Of Ordinal Outcomes Rating; Infectious Diseases; Nested Trials; Platform Trial; Pragmatic Trials; Staph Aureus Bacteremia

$539,325

A Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP)

Co-investigatorCIHR2024Project Grant

Principal investigators: Cheng, Matthew P; Bai, Anthony D; Daley, Peter; Daneman, Nick; Grant, Jennifer; Lawandi, Alexander; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Somayaji, Ranjani; Wuerz, Terence

Keywords: Bacteremia; Bloodstream Infection; Clinical Trial; Oral Antibiotics; Staphylococcus Aureus

$1,705,952

Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)

Co-investigatorCIHR2022Operating Grant: Clinical Trials Projects

Principal investigators: Lee, Todd C; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Johnstone, Jennie; Lawandi, Alexander; Lye, David C; McDonald, Emily G; Paul, Mical; Tong, Steven; Walls, Genevieve; Wuerz, Terence

Keywords: Combination Therapy; Endocarditis; Randomized Controlled Trial; Staphylococcus Aureus Bacteremia

$1,999,745

Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)

Co-investigatorCIHR2022Operating Grant: Clinical Trials Projects - Indirect Costs

Keywords: Combination Therapy; Endocarditis; Randomized Controlled Trial; Staphylococcus Aureus Bacteremia

$499,936

The S. aureus Network Adaptive Platform Trial (SNAP) Canada: A Randomized Controlled Trial for Penicillin-susceptible, Methicillin-susceptible, and Methicillin-resistant Staphylococcus aureus Bloodstream Infections in Hospitalized Patients

Co-investigatorCIHR2020Project Grant

Principal investigators: Cheng, Matthew P; Daneman, Nick; Johnstone, Jennie; Lee, Todd C

Keywords: Bacteremia; Randomized Controlled Trial; Staphylococcus Aureus

$1,139,852

Effectiveness of Identifying C. difficile Asymptomatic Carriers on the Incidence of C. difficile Infection (EFFICACI): A Stepped Wedge Cluster Randomized Trial

Co-investigatorCIHR2020Project Grant

Principal investigators: Longtin, Yves; Lee, Todd C; Loo, Vivian G; McDonald, Emily G

Keywords: Antibimicrobial Stewardship; Asymptomatic Carriage; Clostridium Difficile Infection; Infection Prevention And Control; Interventional Study; Isolation Precautions; Population-Based Research; Stepped Wedge Cluster Randomized Trial

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Dominik Mertz

Research

Latest papers

Latest funding

Trends in health care–associated infections in acute care hospitals in Canada: an analysis of repeated point-prevalence surveys

The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009–2015)

Treatment of Enterococcal Bacteremia Platform (TENT)

An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform

Clopidogrel vs. Aspirin in S. aureus Bacteremia (Clopido-SNAP)

Dabigatran for the adjunctive treatment of Staphylococcus aureus bacteremia: the DABI-SNAP nested randomized controlled trial

A Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP)

Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)

Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)

The S. aureus Network Adaptive Platform Trial (SNAP) Canada: A Randomized Controlled Trial for Penicillin-susceptible, Methicillin-susceptible, and Methicillin-resistant Staphylococcus aureus Bloodstream Infections in Hospitalized Patients

Effectiveness of Identifying C. difficile Asymptomatic Carriers on the Incidence of C. difficile Infection (EFFICACI): A Stepped Wedge Cluster Randomized Trial

Frequent collaborators

Dominik Mertz

Michelle Science

Dominik Mertz

Dominik Mertz

Monica Taljaard

Allison McGeer

Monica Taljaard

Monica Taljaard

Stephanie Smith

Susy Hota

Allison McGeer

Yves Longtin

Andrew Simor

Yves Longtin

Nisha Thampi

Nisha Thampi

Kathryn Bush

Monica Taljaard